Table 1. Study Population and Demographics for Healthy Control and CRS Patients.
Data is presented as frequencies (percentages), means +/− standard deviation or medians with interquartile range.
| Healthy Control | All CRS | CRSsNP | CRSwNP | |
|---|---|---|---|---|
| No. | 17 | 90 | 37 | 53 |
| Age (years) | 50.5 +/− 13.1 | 48.5 +/− 13.1 | 47.7 +/− 13.3 | 49.0 +/− 13.1 |
| Sex, no. (% female) | 13 (76) | 42 (47) | 21 (57) | 21 (40) |
| Asthma, no. (%) | 0 (0) | 44 (49) | 12 (32) | 32 (60) |
| Allergic Rhinitis, no. (%) | 1 (6) | 56 (62) | 20 (54) | 36 (68) |
| AERD, no. (%) | - | 11 (12) | 0 (0) | 11 (21) |
| AFS, no. (%) | - | 10 (11) | 0 (0) | 11 (21) |
| SNOT-22 score | - | 47.1 +/− 18.7 | 48.5 +/− 16.3 | 46.1 +/− 20.4 |
| CT score | 1.0 (0.0-3.6) | 16.0 (11.0-20.0) | 12.0 (9.0-15.3) | 17.5 (14.8-22.0) |
| SIT score | −4.0(−7.0–1.0) | −7.0(−24.5–3.0) | −3.0 (−6.8–1.0) | −20.0 (−27.0–7.0) |
| Prior surgery, no. (%) | - | 43/90 (48) | 13 (35) | 30 (57) |
AERD, aspirin-exacerbated respiratory disease; AFRS, allergic fungal rhinosinusitis; CRS, chronic rhinosinusitis; CRSsNP, chronic rhinosinusitis without nasal polyps; CRSwNP, chronic rhinosinusitis with nasal polyps; CT, computed tomography; SIT, smell identification test; SNOT-22, sinonasal outcome test-22.